Dr SOMME Laura

Impairments in mitochondrial dynamics and morphology in skeletal muscle of breast cancer patients after a single paclitaxel administration.

Mallard J, Hucteau E, Somme L, Bischoff H, Demais V, Silvestrin P, Charles AL, Schott R, Pivot X, Hureau TJ, Pagano AF

Exp Physiol. 2026 07 1;:

Prognostic value of [F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan.

Frega J, Somme L, Martin T, Petit T, Salvadori J, Bund C, Somme F

Eur J Nucl Med Mol Imaging. 2026 07 1;:

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma : FROST: multimodal treatment for GBM recurrence.

Barbe-Richaud JB, Cebula H, Todeschi J, Santin MDN, Baloglu S, Schott R, Cotton M, Blouet A, Bobin M, Noël G, Somme L

J Neurooncol. 2026 06 23;178(3):

Effectiveness of pegylated liposomal doxorubicin (Caelyx®) monotherapy in patients with metastatic HER2-low breast cancer: a monocentric retrospective study.

Boudier P, Bischoff H, Somme L, Pflumio C, Kalish M, Fischbach C, Velten M, Petit T

Cancer Treat Res Commun. 2026 06 10;48:101276

Prolonged complete metabolic response to chemotherapy combined with amivantamab with high grade cutaneous toxicity after osimertinib resistance in an uncommon -mutant lung adenocarcinoma: a case report.

Barbe-Richaud JB, Pencreach E, Schott R, Holder E, Somme L

Transl Lung Cancer Res. 2026 04 30;15(4):110

NF-κB signaling drives rapid skeletal muscle atrophy in patients with breast cancer: The cost of fighting cancer with chemotherapy.

Mallard J, Debrut L, Hucteau E, Somme L, Bischoff H, Moinard-Butot F, Coliat P, Bendjama A, Weltzer L, Sharifi Tafreshi A, Billand C, Charlot A, Boutonnet L, Laverny G, Keime C, Favret F, Schott R, Pivot X, Hureau TJ, Pagano AF

Am J Physiol Cell Physiol. 2026 04 16;:

Feasibility and Potential Effects of Exercise Training Combining Eccentric and Concentric Cycling in Patients With Breast Cancer.

Hucteau E, Hureau TJ, Decor A, Weltzer L, Kouzkouz N, Bischoff H, Somme L, Schott R, Pivot X, Pagano AF, Mallard J

Eur J Sport Sci. 2026 04;26(4):e70153

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial.

Moinard-Butot F, Barbe-Richaud JB, Lasvergnas J, Ancel J, Justeau G, Le Floch H, Somme L, Chouaid C, Bylicki O, Schott R

ESMO Open. 2026 01 29;11(2):106042

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review.

Bischoff H, Gendarme S, Somme L, Chouaid C, Schott R

Curr Oncol. 2025 11 6;32(11):

Real-world survival and prognostic factors in WHO 2021 classified gliomas treated with chemo-radiotherapy.

Bilski M, Noël G, Smółka K, Kuncewicz K, Kuźnicki W, Feuvret L, Korab K, Peszyńska-Piorun M, Korona P, Baranowska I, Suleja A, Le Fevre C, Schott R, Somme L, Chabli S, Mesny E, Mastroleo F, Kotecha R, Jurkiewicz J, Fijuth J, Jereczek-Fossa BA, Krystkiewicz K, Harat M, Kuncman Ł

Sci Rep. 2025 10 30;15(1):38011

Optimizing Post-Neoadjuvant Treatment in Early Triple-Negative Breast Cancer.

Bischoff H, Somme L, Petit T

Cancers (Basel). 2025 10 10;17(20):

First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.

Bischoff H, Fattori A, Moinard-Butot F, Schneegans O, Diaz P, Reita D, Rimelen V, Voegeli AC, Bender L

Thyroid. 2025 05 16;:

EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in C

Barbe-Richaud JB, Fattori A, Lindner V, Schuster C, Malouf G, Pencreach E, Somme L

J Clin Med. 2025 04 30;14(9):

Case report: Long-term response to a combination of immune checkpoint inhibitors as a single treatment for multiple synchronous cancers: a case study.

Ghammem N, Bischoff H, Chiappa P, Somme L, Moinard-Butot F

Front Immunol. 2024 12 16;15:1487227

Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma.

Benistant L, Reita D, Schenck M, Castelain V, Cebula H, Lhermitte B, Bender L

Ann Clin Transl Neurol. 2024 10 23;:

Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and combined with abemaciclib, in recurrent/advanced ER-positive endometrioid endometrial cancer: Results from the phase 1a/1b EMBER study.

Yonemori K, Boni V, Min KG, Meniawy TM, Lombard J, Kaufman PA, Richardson DL, Bender L, Okera M, Matsumoto K, Giridhar KV, García-Sáenz JA, Prenen H, de Speville Uribe BD, Dizon DS, Garcia-Corbacho J, Van Nieuwenhuysen E, Li Y, Estrem ST, Nguyen B, Bacchion F, Ismail-Khan R, Jhaveri K, Banda K

Gynecol Oncol. 2024 10 22;191:172-181

Brain Metastases as Inaugural Sign of Non-Small Cell Lung Carcinoma: Case Series and Review of Literature.

Pușcașu A, Moinard-Butot F, Nannini S, Fischbach C, Schott R, Bender L

Cancers (Basel). 2024 09 8;16(17):

A Hangover Under 177 Lu-PSMA-617 Therapy : A Red Flag for Brain 68 Ga-PSMA-11 PET/MRI?

Poterszman N, Somme L, Bund C, Hutt E, Somme F

Clin Nucl Med. 2024 06 1;49(6):582-583

Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers.

Somme LB, Chouaid C, Moinard-Butot F, Barbe-Richaud JB, Greillier L, Schott R

BioDrugs. 2024 05 20;:

A single chemotherapy administration induces muscle atrophy, mitochondrial alterations and apoptosis in breast cancer patients.

Mallard J, Hucteau E, Bender L, Moinard-Butot F, Rochelle E, Boutonnet L, Grandperrin A, Schott R, Pflumio C, Trensz P, Kalish-Weindling M, Charles AL, Gény B, Favret F, Pivot X, Hureau TJ, Pagano AF

J Cachexia Sarcopenia Muscle. 2024 01 6;:

Primary resistance to ALK inhibitors in -rearranged pleural metastatic lung adenocarcinoma: a case report.

Siblini L, Schott R, Trensz P, Pencreach E, Bender L

Transl Lung Cancer Res. 2023 11 30;12(11):2342-2346

Anaplastic Lymphoma Kinase Inhibitor-Induced Neutropenia: A Systematic Review.

Moinard-Butot F, Nannini S, Fischbach C, Abdallahoui S, Demarchi M, Petit T, Bender L, Schott R

Cancers (Basel). 2023 10 11;15(20):

Capecitabine efficacy after cycline-dependent-kinase 4/6 inhibitor plus endocrine therapy in metastatic hormone receptor-positive breast cancer.

Bender L, Pflumio C, Trensz P, Pierard L, Kalish M, Fischbach C, Petit T

Cancer Treat Res Commun. 2023 06 25;36:100738

Acquired L718V/ co-mutation and discordant molecular pattern between plasmatic and cerebrospinal fluid in a bone and meningeal metastatic L858R+ non-small cell lung cancer: a case report.

Schultz É, Pencreach E, Rimelen V, Palama A, Holder É, Gantzer J, Bender L

Ann Transl Med. 2023 03 15;11(5):223

68Ga-DOTATOC PET in Extracranial Hepatic and Bone Metastasis of Atypical Refractory Meningioma: A Case Report.

Ghomari CF, Bender L, Lhermitte B, Noël G, Namer IJ, Bund C

Clin Nucl Med. 2023 02 1;48(2):176-178

A propensity score-weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer.

Bischoff H, Bigot C, Moinard-Butot F, Pflumio C, Fischbach C, Kalish M, Kurtz JE, Pierard L, Demarchi M, Karouby D, Coliat P, Pivot X, Petit T, Cox DG, Goepp L, Bender L, Trensz P

Breast Cancer Res Treat. 2022 12 23;: